DCF — HARRISON MEDICAL CENTER
Enterprise Value: $20.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$20.9M
Enterprise Value
$-10.8M
PV of Cash Flows
$31.7M
PV of Terminal Value
$51.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $673.0M | $18.3M | 3.0% | $-10.6M | $-9.6M |
| Year 2 | $693.2M | $25.8M | 4.0% | $-5.7M | $-4.7M |
| Year 3 | $714.0M | $33.7M | 5.0% | $-0.5M | $-0.4M |
| Year 4 | $735.4M | $38.4M | 5.0% | $2.3M | $1.5M |
| Year 5 | $757.5M | $41.4M | 5.0% | $3.7M | $2.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $20.9M. Terminal value accounts for 152% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$653.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.022186749318400954
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5